National Cancer Institute

Vilnius LT-08660

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Locally Advanced Solid Tumors, Metastatic Castration-resistant Prostate Cancer, Metastatic Solid Tumors, Prostatic Neoplasms, Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed
• The OPBC-07/microNAC Study — Running, not enrolling
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer — Completed
• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed
• Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer — Completed